Hudock Inc’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Hudock Inc’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-500	Closed	-$21K	–	688
2017 Q3	$21K	Hold	500	–	–	0.01%	344
2017 Q2	$21K	Hold	500	–	–	0.01%	329
2017 Q1	$20K	Hold	500	–	–	0.01%	326
2016 Q4	$19K	Hold	500	–	–	0.01%	320
2016 Q3	$22K	Sell	500 -400	-44%	-$18.2K	0.01%	311
2016 Q2	$37K	Hold	900	–	–	0.02%	266
2016 Q1	$36K	Hold	900	–	–	0.02%	272
2015 Q4	$46K	Hold	900	–	–	0.02%	221
2015 Q3	$42K	Hold	900	–	–	0.02%	233
2015 Q2	$56K	Hold	900	–	–	0.03%	194
2015 Q1	$56K	Hold	900	–	–	0.02%	200
2014 Q4	$49K	Hold	900	–	–	0.02%	209
2014 Q3	$48K	Hold	900	–	–	0.03%	209
2014 Q2	$47K	Hold	900	–	–	0.05%	217
2014 Q1	$42K	Hold	900	–	–	0.03%	222
2013 Q4	$40K	Hold	900	–	–	0.03%	219
2013 Q3	$35K	Hold	900	–	–	0.03%	201
2013 Q2	$32K	Buy	+900	New	+$30.4K	0.05%	208

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Hudock Inc's XPH Position: Q4 2017 in Review

Hudock Inc sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2017, closing a stake of 500 shares — an estimated $21K sold.

Hudock Inc first reported a position in XPH in Q2 2013 and held it in 18 quarters. The position peaked at $56K in Q2 2015. 85 funds tracked by Wall St. Rank hold XPH as of Q4 2017.

Hudock Inc reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2017 after selling out during the quarter.
Hudock Inc sold 500 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2017, an estimated $21K.
Hudock Inc first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 18 quarters.
Hudock Inc's State Street SPDR S&P Pharmaceuticals ETF position peaked at $56K in Q2 2015.
85 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2017.

Based on Hudock Inc's 13F filing for Q4 2017, filed 30 Jan 2018.